On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…
On Jan. 12, 2024, the World Health Organization (WHO) announced it had certified Cabo Verde as a malaria-free…
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
On Jan. 9, 2024, biologists in Alaska have confirmed the first case of a polar bear dying after…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
On Jan. 5, 2024, the U.S. Food and Drug Administration (FDA) authorized Florida’s Agency for Health Care Administration’s…
On Jan. 4, 2024, France announced it had detected bird flu on a duck farm in the Vendee…
On Jan. 4, 2024, AstraZeneca Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, was approved in China for the…